+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

NM23 expression in metastasis of malignant melanoma is a predictive prognostic parameter correlated with survival



NM23 expression in metastasis of malignant melanoma is a predictive prognostic parameter correlated with survival



British Journal of Cancer 70(6): 1224-1228



The management of patients presenting with metastatic malignant melanoma (MM) is hampered by the substantial variability in survival of these patients and the lack of prognostic markers. In the search for a reliable predictive parameter, we have investigated the expression of the nm23 gene, considered to be a major regulator of the metastatic process. We have analysed by Northern blot the nm23 mRNA level in tumour tissue obtained from metastases of 20 stage II and ten stage III patients with MM. Normal human tissues and benign naevi were simultaneously examined. The level of nm23 expression was highly heterogeneous in MM metastases, with a mean value which was higher than the mean level in normal tissues and naevi. Correlative study was focused on the overall survival following resection of the metastasis in which nm23 Northern blot analysis was performed. Patients displaying higher nm23 expression in metastatic tissue (above the mean level) tended to have a longer survival than others (P = 0.08), and this difference was significant for patients presenting with isolated regional lymph node involvement (P = 0.035). The time from biopsy of the primary MM to the appearance of the first lymph node metastasis also showed a positive correlation with the nm23 mRNA level in this metastasis. The present study is not only in accordance with previous reports showing that the nm23 gene may be implicated in MM progression, but also suggests the reliable value of nm23 expression as a prognostic marker for patients presenting with metastatic MM.

Accession: 046759359

Download citation: RISBibTeXText

PMID: 7981081

DOI: 10.1038/bjc.1994.477


Related references

Immunohistochemical expression of nm23 in primary invasive malignant melanoma is predictive of survival outcome. Journal of Pathology 190(2): 157-162, 2000

Prognostic significance of nm23 protein expression in malignant melanoma. An immunohistochemical study. Melanoma Research 7(2): 121-128, 1997

Prognostic significance of nm23-protein expression in malignant melanoma An immunohistochemical study. Pigment Cell Research 0(SUPPL 5): 47, 1996

Expression of metastasis suppressor gene product, nm23 protein, is not inversely correlated with the tumour progression in human malignant melanomas. Histopathology (oxford). 29(6): 497-505, 1996

Lymphatic transit rate as a predictive parameter for nodal metastasis in primary limb malignant melanoma. Journal of Dermatological Science 90(1): 27-34, 2018

MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma. International Journal of Cancer 126(11): 2553-2562, 2010

A comparison of in-situ expression of NM23 with other prognostic factors in breast cancer and its predictive value for progression-free and overall survival. Breast Cancer Research & Treatment 41(3): 248, 1996

Nm23 Gene expression correlates with length of survival in patients with thick cutaneous malignant melanoma. Journal of Pathology 175(SUPPL ): 148A, 1995

Expression of NM23 protein in acquired melanocytic nevi, malignant melanoma and metastases of malignant melanoma: an immunohistological assessment in human skin. Dermatology 194(2): 136-139, 1997

Dermatopathological indicators of poor melanoma prognosis are significantly inversely correlated with the expression of NM23 protein in primary cutaneous melanoma. Journal of Cutaneous Pathology 34(9): 705-712, 2007

Analysis of nm23 expression as a prognostic parameter in renal cell carcinoma. Journal of Korean Medical Science 10(4): 258-262, 1995

Expression of NM23 in human melanoma progression and metastasis. British Journal of Cancer 74(1): 109-114, 1996

The loss of NM23 protein in malignant melanoma predicts lymphatic spread without affecting survival. Anticancer Research 20(5c): 3971-3974, 2001

Metastasis, but not tumorigenicity, is suppressed and NM23 levels are increased by introduction of chromosome 6 into human malignant melanoma cell line C8161. Proceedings of the American Association for Cancer Research Annual Meeting 35(0): 55, 1994

The value of Nm23 expression as an independent prognostic indicator in primary thick melanoma. Journal of Cutaneous Pathology 23(4): 344-349, 1996